SS
Suhail Sayeed Mufti
About Suhail Sayeed Mufti
Data last updated:
Suhail Sayeed Mufti is a Director at James Lind Institute Private Limited (since 2009), Director at Dr. Mufti's Oncopathology And Clinical Reference Laboratory Private Limited (since 2022) and Designated Partner at Clinres Clinical Research Llp (since 2017). The companies operate in Research & Development, Healthcare and Business Services. The largest current company by reported revenue is James Lind Institute Private Limited at ₹83.7 Lakh (FY 2024). Earlier, Suhail Sayeed Mufti was a Designated Partner at Scandinavian Meditech Llp (2022–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 James Lind Institute Private Limited U73100KA2009PTC129275 | Director | 01 May 2009 | 2009 | ₹83.7 Lakh (FY 2024) | Active |
| Dr. Mufti's Oncopathology And Clinical Reference Laboratory Private Limited U85100JK2022PTC014075 | Director | 13 Dec 2022 | 2022 | Active | |
| Clinres Clinical Research Llp AAK-7731 | Designated Partner | 06 Oct 2017 | 2017 | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Scandinavian Meditech Llp AAN-1264 | Designated Partner | 11 Jun 2022 | 2018 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Suhail Sayeed Mufti
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdul Wahid Kamili | 03161891 | James Lind Institute Private Limited | Director |
| Tufail Syed | 09794978 | James Lind Institute Private Limited | Director |
| Beenish Nazir | 09823768 | Dr. Mufti's Oncopathology And Clinical Reference Laboratory Private Limited | Director |
| Firdous Akhter | 02590848 | Clinres Clinical Research Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suhail Sayeed Mufti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suhail Sayeed Mufti
Suhail Sayeed Mufti currently holds 3 directorships: James Lind Institute Private Limited (Director, since 01 May 2009, revenue ₹83.7 Lakh (FY 2024)); Dr. Mufti's Oncopathology And Clinical Reference Laboratory Private Limited (Director, since 13 Dec 2022); Clinres Clinical Research Llp (Designated Partner, since 06 Oct 2017).
Suhail Sayeed Mufti was first appointed on 01 May 2009 as Director at James Lind Institute Private Limited. The most recent appointment on record is 13 Dec 2022 at Dr. Mufti's Oncopathology And Clinical Reference Laboratory Private Limited.
Suhail Sayeed Mufti held 1 earlier board appointment: Scandinavian Meditech Llp (Designated Partner, 11 Jun 2022 to 01 Feb 2025).
The current boards of Suhail Sayeed Mufti's companies include Abdul Wahid Kamili (James Lind Institute Private Limited), Tufail Syed (James Lind Institute Private Limited), Beenish Nazir (Dr. Mufti's Oncopathology And Clinical Reference Laboratory Private Limited), Firdous Akhter (Clinres Clinical Research Llp).